Clinical and translational science award


The National Institutes of Health (NIH) formulated the Clinical and Translational Science Award (CTSA) in the early 2000s with the goal of coordinating research across disciplines, across institutions, across the country.  Meharry, in partnership with Vanderbilt University, received a Clinical and Translational Science Award in 2007, and then again in 2012, and now all 60 CTSAs have been awarded by the NIH. Vanderbilt serves as the lead institution for the nationwide consortium.

The strategic goals guiding the consortium are:

  • Build national clinical and translational research capacity
  • Provide training and improve career development of clinical and translational scientists
  • Enhance consortium-wide collaborations
  • Improve the health of our communities and the nation
  • Advance T1 translational research to move basic laboratory discoveries and knowledge into clinical testing

Translational research 'translates' laboratory discoveries into treatments and cures. Clinical research is the testing phase of those treatments and cures in the clinical setting among patients. The overall intent of the CTSA Consortium is to facilitate the translation of research from the bench, to the bedside, to the community.

In addition to providing infrastructure support to the College, Meharry's CTSA leads the Community Engagement Research Core (CERC) for Vanderbilt and Meharry.  One of the major goals of the CERC is to partner with community health care organizations and community physicians and set up academic-community networks to enhance health for all.

Members of the Meharry component of the CTSA are:

Russell E. Poland, Ph.D., Co-Program Director for the CTSA
Jared Elzey
Margaret Hargreaves, Ph.D.
Desiree Johnson
Robert Levine, M.D.
John Murray, M.D., Ph.D.
Bogdan Nowicki, M.D., Ph.D.
Maureen Sanderson, Ph.D.
Lauren Solberg, J.D.
Steven Wolff, M.D.